3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Urologic Neoplasms
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Postoperative Hemorrhage
1
Postoperative Complications
1
Pancreatic Adenocarcinoma
1
Pain, Postoperative
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Hypotension
1
Cognitive Dysfunction
1
Chronic Pain
1
Breast Carcinoma In Situ
1
Agnosia
1
Acute Pain
1
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Platinum
6
Cyclophosphamide
6
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
atezolizumab
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Anesthesia, General
×
1 year
×
Clear all
No trials found.